C14H19N5O4S
Neat
353.40
Gefapixant; 1015787-98-0; AF-219; Benzenesulfonamide, 5-[(2, 4-diamino-5-pyrimidinyl)oxy]-2-methoxy-4-(1-methylethyl)-; RO4926219; RG-1646; 6K6L7E3F1L; Ro-4926219; 5-[(2, 4-diaminopyrimidin-5-yl)oxy]-2-methoxy-4-(propan-2-yl)benzene-1-sulfonamide; R-1646; DTXSID401337212; 5-(2, 4-diaminopyrimidin-5-yl)oxy-2-methoxy-4-propan-2-ylbenzenesulfonamide; Benzenesulfonamide, 5-((2, 4-diamino-5-pyrimidinyl)oxy)-2-methoxy-4-(1-methylethyl)-; gefapixantum; 5-((2 and 4-diaminopyrimidin-5-yl)oxy)-2-methoxy-4-(propan-2-yl)benzene-1-sulfonamide; RefChem:639790; DTXCID601767631; Gefapixant [USAN]; MFCD24539325; C14H19N5O4S
5-(2 and 4-diaminopyrimidin-5-yl)oxy-2-methoxy-4-propan-2-ylbenzenesulfonamide
InChI=1S/C14H19N5O4S/c1-7(2)8-4-10(22-3)12(24(17,20)21)5-9(8)23-11-6-18-14(16)19-13(11)15/h4-7H,1-3H3,(H2,17,20,21)(H4,15,16,18,19)